Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: Comparison with tumor volume measurements

American Journal of Neuroradiology

Volumn 30, Issue 4, 2009, Pages 793-799

  Bisdas, S ^a,b,d   Rumboldt, Z ^b   Wagenblast, J ^a   Baghi, M ^a   Koh, T S ^c   Hambek, M ^a   Vogl, T J ^a   Mack, M G ^a  

^a GOETHE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; IODINATED CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD VOLUME; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; ENDOSCOPY; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; OROPHARYNX CARCINOMA; PERFUSION COMPUTED TOMOGRAPHY; PROGRESSION FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD FLOW VELOCITY; BLOOD VOLUME; CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; DISEASE PROGRESSION; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 64549161120     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1449     Document Type: Article

References (35)

1. Hitt R, Ciruelos E, Amador ML, et al. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy. Eur J Cancer 2005;41:453-60
2. Shiga H, Heath EI, Rasmussen AA, et al. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res 1999;5:4097-104
3. Mendenhall WM, Morris CG, Amdur RJ, et al. Parameters that predict local control after definitiveradiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003;25:535-42
4. Massano J, Regateiro FS, Januario G, et al. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:67-76
5. Marcus B, Arenberg D, Lee J, et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 2004;101:2779-87
6. Ojiri H, Mendenhall WM, Stringer SP, et al. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002;52:420 -28
7. Mukherji SK, O'Brien SM, Gerstle RJ, et al. The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglotticlarynx. Head Neck 2000;22:282-87
8. Pameijer FA, Mancuso AA, Mendenhall WM, et al. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 1997;37:1011-21
9. Plataniotis GA, Theofanopoulou ME, Kalogera-Fountzila A, et al. Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma(non-nasopharyngeal)treatedbyradiotherapyaloneorcombined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys 2004;59:1018-26
10. Baghi M, Mack MG, Hambek M, et al. Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy. Head Neck 2007;29:104-08
11. Ljumanovic R, Langendijk JA, Schenk B, et al. Supraglottic carcinoma treated with curative radiation therapy:identification of prognostic groups with MR imaging. Radiology2004;232:440-48
12. Schmitt P, Kotas M, Tobermann A, et al. Quantitative tissue perfusion measurements in head and neck carcinoma patients before and duringradiation therapy with a non-invasive MR imaging spin-labeling technique. Radiother Oncol 2003;67:27-34
13. Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 2000;57:39-43
14. Wouters BG, Weppler SA, Koritzinsky M, et al. Hypoxia as a target for combined modality treatments. Eur J Cancer 2002;38:240-57
15. Zima A, Carlos R, Gandhi D, et al. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 2007;28:328-34
16. Hermans R, Meijerink M, Van den Bogaert W, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts out-come in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351-56
17. Gandhi D, Chepeha DB, Miller T, et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006;27:101-06
18. Hoskin PJ, Saunders MI, Goodchild K, et al. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 1999;72:1093-98
19. Bisdas S, Baghi M, Smolarz A, et al. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer,recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography. Studies Invest Radiol 2007;42:172-79
20. Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr 2003;27:687-93
21. Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol 2005;26:1178-85
22. Hermans R, Lambin P, Van den Bogaert W, et al. Non-invasive tumour perfusion measurement by dynamic CT: preliminary results. Radiother Oncol 1997;44:159-62
23. Breiman RS, Beck JW, Korobkin M, et al. Volume determinations using computed tomography. AJR Am J Roentgenol 1982;138:329-33
24. Walters SJ, Campbell MJ. The use of bootstrap methods for analysing Health-Related Quality of Life outcomes (particularly the SF-36). Health Qual Life Outcomes 2004;2:70
25. Mancuso AA, Mukherji SK, Schmalfuss I, et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999;17:631-37
26. Hermans R, Van den Bogaert W, Rijnders A, et al. Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:755-65
27. Keberle M, Hoppe F, Dotzel S, et al. [Prognostic value of pretreatment CT regarding local control in oropharyngeal cancer after primary surgical resection]. Rofo 2003;175:61-66
28. KurekR, Kalogera-Fountzila A, Muskalla K, et al. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 2003;179:292-97
29. Hermans R, Op de beeck K, Van den Bogaert W, et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2001;50:37-45
30. Nathu RM, Mancuso AA, Zhu TC, et al. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck 2000;22:1-5
31. Nordsmark M, Overgaard M, Overgaard J.Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-39
32. Tannock IF. Experimental chemotherapy and concepts related to the cell cycle. Int J Radiat Biol Relat Stud Phys Chem Med 1986;49:335-55
33. Bisdas S, Foo CZ, Thng CH, et al. Optimization of perfusion CT protocol for imaging of extracranial head and neck tumors. J Digit Imaging2008 May3 [E pub ahead of print]
34. Bisdas S, Konstantinou GN, Lee PS, et al. Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis. Phys Med Biol 2007;52:6181-96
35. Klug C, Keszthelyi D, Ploder O, et al. Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patients. Head Neck 2004;26:224-31